Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
NCT01851200
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Germ Cell Cancer
Interventions
DRUG:
Brentuximab Vedotin
Sponsor
Fondazione Michelangelo
Collaborators
[object Object]
[object Object]